B-75/100

Is Veeva Systems Inc (VEEV) a risky stock?

Sector: Health Care Price: $194.68 Composite: 75/100

As of July 21, 2026, Clavix grades Veeva Systems Inc (VEEV) B- for risk, a composite score of 75 out of 100 on an A+ to F scale, which puts VEEV in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind VEEV's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how VEEV scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
87
News sentimentscored, sourced recent coverage
51
Macro exposuresensitivity to rates, dollar, oil
65
Sector resiliencestrength vs the broad market
71
Price stabilitydrawdown and volatility
35

What's moving VEEV's risk right now

Company-specific signals Clavix flags behind VEEV's current grade, drawn from recent news and filings as of July 21, 2026.

Price volatility · raising risk

Elevated price volatility is increasing short-term risk and may signal uncertainty about near-term fundamentals.

Regulatory · mixed signal

A new institutional investor has taken an initial stake in VEEV, signaling fresh institutional confidence in the stock during Q1, though a single new 13F filing has limited direct…

Earnings & results · mixed signal

The Russell index removal likely triggered forced selling from index-tracking funds, which may have created a buying opportunity as the underlying earnings trends remain solid and…

What a B- grade means

On the Clavix A+ to F scale, VEEV's composite of 75 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell VEEV or any security. Grades are risk indicators, not predictions of return. Data may be delayed.